Data / Form D filings / Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd.: Form D filings
Quoin Pharmaceuticals Ltd., a pharmaceuticals company in Ashburn, VA, filed 5 Form D notices with the SEC between 2017 and 2026. The latest, on September 10, 2026, reports $50 million sold of a $50 million offering to 33 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 42127 PLEASANT FOREST COURT, Ashburn, VA, 20148
- Phone
- (703) 980-4182
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1671502
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | New notice | $50,000,649 | $50,000,649 | 33 | Aug 31, 2026 | sec.gov | |
| Oct 23, 2025 | New notice | $105,254,891 | $105,254,891 | 27 | Oct 14, 2025 | sec.gov | |
| Aug 31, 2022 | New notice | $193,537 | $193,537 | 1 | Aug 23, 2022 | sec.gov | |
| Feb 9, 2018 | New notice | $3,999,996 | $3,999,996 | 3 | Jan 31, 2018 | sec.gov | |
| Sep 19, 2017 | New notice | $4,303,000 | $4,302,202 | $798 | 18 | Sep 11, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Myers | Executive Officer, Director | |
| Sally Bridget Lawlor | Executive Officer | |
| Denise Carter | Executive Officer, Director | |
| Joseph Cooper | Director | |
| James Culverwell | Director | |
| Dennis Langer | Director | |
| Natalie Leong | Director | |
| Michael Sember | Director |
Every Form D from the week of Sep 7, 2026 · All recent filings in Virginia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Quoin Pharmaceuticals Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.